The article discusses on how peptides in the serum of cancer patients can be use for the detection and classification of cancer. A mass-spectrometry approach has been developed to determine tumor-specific peptidome patterns in serum samples. The researchers used an automated procedure for the simultaneous measurement of peptides in serum.